-+ 0.00%
-+ 0.00%
-+ 0.00%

ACADIA Pharmaceuticals Affirms FY2026 Sales Guidance of $1.220B-$1.280B vs $1.247B Est

Benzinga·05/06/2026 20:19:11
Listen to the news
ACADIA Pharmaceuticals (NASDAQ:ACAD) affirms FY2026 sales outlook from $1.220 billion-$1.280 billion to $1.220 billion-$1.280 billion vs $1.247 billion estimate.